Krystal Biotech's VYJUVEK shows strong growth, with 2025 sales expected to exceed $1B, bolstered by launches in the EU and Japan. Q4 earnings beat EPS expectations but slightly missed revenue ...

PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth ...

Krystal Biotech reported $91.1 million in Q4 2024 VYJUVEK revenue vs. analysts’ revenue estimate of $91.35 million. Adjusted EPS was $1.58 per basic share vs. analysts’ EPS estimate of $1.85.

Krystal Ortiz joined FOX 10 News in July 2022 as a meteorologist on the FOX 10 Weather Experts. An Arizona native, Krystal is thrilled to forecast for her hometown and rediscover her favorite ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...

After hours: March 12 at 4:19:01 PM EDT Loading Chart for KRYS ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.